Sopharma AD (WSE:SPH)
12.75
-0.25 (-1.92%)
Dec 4, 2025, 6:59 PM CET
Sopharma AD Revenue
Sopharma AD had revenue of 641.57M BGN in the quarter ending September 30, 2025, with 18.09% growth. This brings the company's revenue in the last twelve months to 2.51B, up 22.13% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.
Revenue (ttm)
2.51B BGN
Revenue Growth
+22.13%
P/S Ratio
0.57
Revenue / Employee
448.40K BGN
Employees
5,599
Market Cap
3.12B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
| Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
| Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
| Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
| Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |